SCHEMBL21065110

SCHEMBL21065110

CC(C)Oc1ncccc1-c1cc(C2CCCN2)on1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 4/20 0.47
HCRTR1 O43613 3/20 0.47
CHRNB2 P17787 1/20 0.46
CHRNA4 P43681 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.39
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
PDCD1LG2 Q9BQ51 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
CHRM5 P08912 3/20 0.36
CHRM3 P20309 3/20 0.36
CHRM1 P11229 2/20 0.36
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21065109 1.00 HCRTR2 (0.47) HCRTR2HCRTR1CHRNB2CHRNA4IRAK4
SCHEMBL3852338 0.89 CHRNB2 (0.47) HCRTR2HCRTR1CHRNB2CHRNA4IRAK4
SCHEMBL3852340 0.89 CHRNB2 (0.47) HCRTR2HCRTR1CHRNB2CHRNA4IRAK4
SCHEMBL21065180 0.87 HCRTR1 (0.47) HCRTR2HCRTR1CHRNB2CHRNA4CHRNB4
SCHEMBL21065184 0.87 HCRTR1 (0.47) HCRTR2HCRTR1CHRNB2CHRNA4CHRNB4
SCHEMBL3918221 0.83 CHRNB2 (0.50) CHRNB2CHRNA4IRAK4CHRM5CHRM3
SCHEMBL3922331 0.83 CHRNB2 (0.50) CHRNB2CHRNA4IRAK4CHRM5CHRM3
SCHEMBL3922338 0.81 CHRNB2 (0.50) CHRNB2CHRNA4IRAK4PDCD1LG2CD274
SCHEMBL3919389 0.81 CHRNB2 (0.50) CHRNB2CHRNA4IRAK4PDCD1LG2CD274
SCHEMBL3930353 0.80 CHRNB2 (0.47) CHRNB2CHRNA4IRAK4CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906553-B1 OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2019-06-26 EP disclosed